Hipolipemiczne dzialanie bialka nasion roslin straczkowych

• Autorzy: Nowicka G , Panczenko-Kresowska B.

Warianty tytułu

EN

Hypocholesterolemic effect of grain legumes protein

• Języki publikacji: PL

Słowa kluczowe

PL

soja; choroba niedokrwienna serca; choroby czlowieka; rosliny straczkowe; dieta; dzialanie hipocholesterolemiczne; bialka roslinne; lubin; zywienie czlowieka

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2005
• Tom: 32
• Numer: 1
• Opis fizyczny: s.47-55,bibliogr.

Twórcy

autor

Nowicka G

• Instytut Zywnosci i Zywienia, Warszawa

autor

Panczenko-Kresowska B.

Bibliografia

• 1. Alercreutz H.: Epidemiology of phytoestrogenes: Ballieres Chem. Endocrinol. Metab., 1998, 12, 605-29.
• 2. Anderson J. W., Gustafson N., Spencer D., et al.: Serum lipid response of hypercholesterolemic men to single and divided doses of canned beans. Am. J. Clin. Nutr., 1990, 51, 1013-19.
• 3. Anderson J. W., Johnstone B. M., Cook-Newell M. E.: Meta-analysis of the effects of soybean protein intake on serum lipids. N. Engl. J. Med., 1995, 333, 276-82.
• 4. Anderson J. W, Major A. W: Pulses and lipaemia short- and long-term effect: potental in the prevention of cardiovascular disease. Br. J. Nutr., 2002, 88, Suppl. 3, S 263-71.
• 5. Anderson J. W, Smith B. M., Washnock C. S.: Cardiovascular and renal benefis of dry been and soybean intake. Am. J. Clin. Nutr., 1999, 70 Suppl. 464, S-474S.
• 6. Anderson J. W, Smith B., Moore K., et al.: Soy foods and health promotion. Vegetables, fruits and herbs for Health Promotion. Ed: R. Watson, E L. Boca Raton.: CRC Press. 2000, p. 117-134.
• 7. Anthony M. S., Clarkson T. B., Weddle D. L., et al.: Effects of soy protein phytoestrogens on cardiovascular risk factors in rhesus monkeys. J. Nutr. 1995, 125. Suppl. 3, S 803-805.
• 8. Brown L., Rosner B., Willet W, et al.: Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am. J. Clin. Nutr., 1999, 69, 30-42.
• 9. Champ M.: Benefits of pulses in human diet. In: Proceedings of 4th European Conference on Grain Legumes. Valladolid. Ed: AER 2001, p. 109-113.
• 10. Chango A., Villaume C., Ban H. M., et al.: Effects of casein, sweet white lupin and sweet yelow lupin on cholesterol metabolism in rats. J. Sei. Food Agrie., 1998, 76, 303-9.
• 11. Clarke R., Lewington S., Youngman L., et al.: Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age. Eur. Heart. J., 2002, 23, 286-93.
• 12. Clarkson T. B.: Soysoyphytoestrogens and cardiovascular disease. J. Nutr., 2002, 32, 566 S- 69S.
• 13. Descovich G., Gaddi A., Mannino G., et al.: Multicenter study of soybean protein diet for outpatient hypercholesterolemia patients. Lancet, 1980, 2, 709-12.
• 14. Desroches S., Mauger J. E, Ausman L. M., et al.: Soy protein favorably affects LDL size indepenently of isoflavones in hypercholestero- lemic man and women. J. Nutr., 2004, 134, 574-79.
• 15. Food and Drug Administration 1999, Food labeling: health claims: soy protein and coronary heart disease. 21CFR. Part 101, Fed. Regist.64, 57700-57733.
• 16. Fruhbeck G., Monreal I., Santidrian S.: Hormonal implications of the hypocholesterolemic effect of intake of field beans (Vicia faba) by young men with hypercholesterolemia. Am. J. Clin. Nutr., 1997, 66, 1452- 1460.
• 17. Fukui K., Tachibana N, Wanezaki S., et al.: Isoflavone-free soy protein prepared by column chromatography reduces plasma cholesterol in rats. J. Agrie. Food Chem., 2002, 50, 5717-21.
• 18. Fumagalli R., Soleri L., Musanti R., et al.: Fecal cholesterol excretion studies in type II hypercholesterolemia patients treated with the soybean protein diet. Atherosclerosis, 1982, 43, 341-52.
• 19. Gaddi A., Ciarocchi A., Mattencci A., et al.: Dietary treatment for familial hypercholesterolemia-differential effects of dietary soy protein according to the apolipoprotein E phenotypes. Am. J. Clin. Nutr., 1991, 53, 1191-96.
• 20. Gaddi A., Descovich G. C., Noseda G., et al.: Hypercholesterolemia treated by soybean protein diet. Arch. Dis. Child., 1987, 62, 274-78.-
• 21. Graves K. A., Wilson M. D., Rudel L. L., et al.: Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract in ovariectomized cynomolgus monkeys. J. Nutr., 2000, 130, 820- 26.
• 22. Jenkins D. J., Wolever T. M., Jenkins A. L., et al.: The glycemic index of food tested in diabetic patients. A new basis for carbohydrate exchange favouring the use of legumes. Diabetologia, 1983, 24, 257-64.
• 23. Jenkins D. J. A., Wolever T., Jenkins A. L.: Starchy foods and glycemic index. Diabetes Care, 1988, 11,149-59.
• 24. Jones P J: Clinical nutrition: Functional foods- more than just nutrition. Can. Med. Assoc. J., 2002, 166, 1555-63
• 25. Keys A.: Seven countrie study: a multivarite analysis of death and j coronary heart disease. Cambridge. MA.: Harvard University Press., 1980
• 26. Kurowska E. M, Caroll K. K, Znang Z. J., et al.: Regulation of synthesis and secretion of LDL apoprotein B by essential amino acids. Proc. Can. Fed. Biol. Soc., 1993, 136 (abst.525).
• 27. Leterme P: Recommendations by health organizations for pulse consumption. Br. J. Nutr., 2002, 88. Suppl. 3, S 239-42
• 28. Lichtenstein A. H.: Got soy?. Am. J. Clin. Nutr., 2001, 73, 667-68.
• 29. Liu S., Willet W. C., Stampfer M. J., et al.: A prospective study of dietary glycemic load, carbohydrate intake and risk of coronary heart disease in US women. Am. J. Clin. Nutr., 2000, 71, 1455-61.
• 30. Lovati M. R., Manzoni C., I Corsini A., et al.: Low density lipoprotein (LDL) receptor activity is modulated by soybean globulins in cell culture. J. Nutr, 1992, 122, 1971-78.
• 31. Lovati M. R, Manzoni C, Corsini A, et al.: 7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system. J. Nutr., 1997, 126, 2831-43.
• 32. Lovati M. R, Manzoni C, Gianazza E, et al.: Soybean protein peptides regulate cholesterol homeostasis in Hep. G2 cell. J. Nutr., I 2000, 130, 2543-49.
• 33. Lovati M. R, Manzonic C, Canavasi A, et al.: Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cell I
• from hypercholesterolemia patients. J. Clin. Invest., 1987, 80, 125-30.
• 34. Lquari H., Vioque J., Pedroche J.: Lupinus angustifoluis protein isolates: chemical composition, functional properties and protein characterisation. Food Chem., 2002, 76, 349-56.
• 35. Manson J., Tosteson H., Ridker P, et al.: The primary prevention of myocardial infraction. N. Engl. J. Med., 1992, 326, 1406-16.
• 36. Manzoni C., Duranti M., Eberini I., et al.: Subcellular localization of soybean 7S globulin in Hep G2 cells and LDL receptor up-regulation by a constituent subunit. J. Nutr., 2003, 2149-55
• 37. Mathers J. C.: Pulses and carcinogenesis: potential for the prevention of colon, breast and other cancers. Br. J. Nutr., 2002, 88, Suppl. 3, S 273-79.
• 38. McGee D., Reed D., Yano K., et al.: Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relatinoship to nutritient intake. Am. J. Epidem., 1984, 119, 667-76.
• 39. Meeker D. R., Kesten H. D.: Effect of high protein diets on experimental atherosclerosis on rabbits. Arch. Pathol., 1941, 31,147-62.
• 40. Navder K. P, Baraona E., Lieber C. S.: Dilinoleoyphoshatidylcholine protects human low lipoproteins against oxidation. Atherosclerosis, 2000, 152, 89-95.
• 41. Nishina P M., Freedland R. A.: The effects of dietary fiber feeding on cholesterol metabolism in rats. J. Nutr., 1990, 120, 800005.
• 42. Polichetti E., Diaconesen N., De la Porte P L., et al. Cholesterol - lowering effect of soybeen lecithin in normolipi- demic rats by stimulation of biliary lipid secretion. Br. J. Nutr., 1996, 75, 471-81.
• 43. Potter S. M.: Soyproteins and cardiovascular disease: the impact of bioactive components in soy. Nutr. Rev.,1998, 56, 231-35.
• 44. Puska P, Korpelainen V, Hoie L. H., et al.: Isolated soy protein with standarised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolemia: a double-blind, placebo-controlled trial of a yoghurt formulation. Br. J. Nutr., 2004, 91, 393-401.
• 45. Rahman M. H., Hossain A., Siddiqua A.: Hematobiochemical parameters in rats fed Lupinus angustifolius L (sweet lupin) seed protein and fiber fraction J. Clin. Biochem. Nutr., 1996, 20, 99-111.
• 46. Report of the Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. Geneva, Switzerland, 2002.
• 47. Riz- kalla S. W, Bellisle E, Slama G.: Health benefis of low glycaemic index food, such as pulses, in diabetic patients and healthy individuals. Br. J. Nutr., 2002, 88, Suppl. 3, S 255-62.
• 48. Sacks E. M., Breslow J. L., Wood P G., Kass E. H.: Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol of strict vegetarians :an experiment and a critical review. J. Lipid Res., 1983, 24, 1012-20.
• 49. Sanchez A., Hubbard R. W: Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med. Hypotheses, 1991, 36, 27-32.
• 50. Sathe S. K., Deshpande S. S., Salunkhe D. K.: Dry beans of phaseolus. A review. Part 2. Chemical composition: Carbohydrates, fiber, minerals, vitamins and lipids. Crit. Rev. Food Sei. Nutr., 1984, 21, 41-93.
• 51. Schwand P, Richter W. O., Weisweiler P: Soybean proteinand serum cholesterol. Atherosclerosis, 1981. 40371-72.
• 52. Sirtori C. R., Agradi E., Conti E, et al.: Soybean-protein diet in the treatment of type II hyperlipoproteinemia. Lancet, 1977, 1275- 77.
• 53. Sirtori C. R., Gianazza E., Manzoni C., et al.: Rola of isoflavones in the cholesterol reduction by soybean proteins in the clinic. Am. J. Clin. Nutr., 1997, 65, 166-7.
• 54. Sirtori C. R., Lovati M. R., Manzoni C., et al.: Proteins of white lupin seed a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in Hep G2 cells. J. Nutr., 2003, 134, 18-23.
• 55. Sitori C. R., Pazzuccioni F., Columbo L.: Double-blind study of the addition of high-protein soy milk cow's milk to the diet of patients with severe hypercholesterolemia and resistance to or intolerance of statins. Br. J. Nutr., 1999, 8292, 79-80.
• 56. Teixeira S. R., Potter S. M., Weigel R., et al.: Effects of feeding 4 levels of soy protein for 3 and 6 weeks on blood lipids and apolipoproteis in moderately hypercholesterolemia men. Am. J. Clin. Nutr., 2000, 71, 1077.
• 57. Twisk J., Gillian-Daniel D. L., Tebon A., et al.: The role of the LDL receptor in apolipoprotein B secretion. J. Clin. Invest., 2000, 105, 521-32.
• 58. Vega-Lopez S., Yeum K. J., Lecker J. L., et al.: Plasma capacity in response to diets high in soy or animal protein with or without isoflavones. Am. J. Clin. Nutr., 2005, 81, 43-9
• 59. Welch G. N., Lascalzo J.: Homocysteine and Atherothrombosis. N. Engl. J. Med., 1998, 338, 1042-50.
• 60. Zhang X., Shu X. O., Gao Y-T., et al. : Soy food consumption is associated with lower risk of coronary disease in Chinese women. J. Nutr., 2003, 133, 2874-8.